Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Select Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. It is a non-diversified fund that focuses on long-term capital appreciation by investing in common stocks of U.S. and non-U.S. companies. In the first quarter, the fund (Investor Class) delivered a return of -8.12%, lagging behind the benchmark, the MSCI World Index’s -3.57% return. Energy and industrials were the top performance contributors at the sector level, while health care and consumer discretionary detracted from performance. In addition, you can check the Fund’s top five holdings to determine its best picks for 2026.
In its first-quarter 2026 investor letter, Oakmark Global Select Fund highlighted IQVIA Holdings Inc. (NYSE:IQV). IQVIA Holdings Inc. (NYSE:IQV) is a US-based provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. On April 14, 2026, IQVIA Holdings Inc. (NYSE:IQV) closed at $175.31 per share. One-month return of IQVIA Holdings Inc. (NYSE:IQV) was 6.29%, and its shares gained 19.59% over the past 52 weeks. IQVIA Holdings Inc. (NYSE:IQV) has a market capitalization of $30.14 billion.
Oakmark Global Select Fund stated the following regarding IQVIA Holdings Inc. (NYSE:IQV) in its Q1 2026 investor letter:
“IQVIA Holdings Inc. (NYSE:IQV) was the top detractor during the quarter. The U.S.-headquartered provider of clinical research services, analytics, and solutions saw the price of its stock decline on AI-related fears despite reporting an in-line fourth quarter and 2026 outlook. Management believes the demand environment has stabilized and leading growth indicators, such as bookings and win rates, are encouraging. They expect IQVIA to be a net beneficiary of AI due to proprietary data, domain expertise, and regulatory and compliance barriers, among other factors. We continue to view IQVIA as a stable, long-cycle business that will benefit from a recovery in client spending in the coming quarters.”
IQVIA Holdings Inc. (NYSE:IQV) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 69 hedge fund portfolios held IQVIA Holdings Inc. (NYSE:IQV) at the end of the fourth quarter, up from 61 in the previous quarter. While we acknowledge the potential of IQVIA Holdings Inc. (NYSE:IQV) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
